ArticlePolymers2025
Shear Bond Strength of Biointeractive Restorative Materials to NeoMTA Plus and Biodentine.
Article in Polymers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Shear Bond Strength Between Calcium Silicate-Based Biomaterials and Glass Ionomer Restorative Materials: An In Vitro Comparative Study.Journal of functional biomaterials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe bonding compatibility between calcium silicate-based bioceramic cements and restorative materials is critical for long-term success in pediatric dentistry. This study compared the shear bond strength (SBS) of contemporary biointeractive restorative materials to two widely used bioceramics, NeoMTA Plus (NM) and Biodentine (BD).
methodsEighty acrylic resin blocks with standardized cavities were filled with either NM or BD (
resultsBD exhibited significantly higher SBS values than NM (
conclusionsBiodentine demonstrated superior bonding stability to restorative materials, with composite resin and giomer performing best. Giomer's bioactivity and ion release make it a viable alternative to composite resin in suitable clinical contexts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.